Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

5α-Reductase inhibitors, like finasteride, can cause serious, persistent side effects not always listed in official drug information.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

The composition helps treat hair loss.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Dock5 is important for skin healing and could help treat diabetic wounds.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Dutasteride may reduce insulin sensitivity and increase body fat.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.